Delcath Total Liab vs Total Stockholder Equity Analysis
DCTH Stock | USD 13.20 1.09 9.00% |
Delcath Systems financial indicator trend analysis is much more than just examining Delcath Systems latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Delcath Systems is a good investment. Please check the relationship between Delcath Systems Total Liab and its Total Stockholder Equity accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Delcath Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Delcath Stock please use our How to Invest in Delcath Systems guide.
Total Liab vs Total Stockholder Equity
Total Liab vs Total Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Delcath Systems Total Liab account and Total Stockholder Equity. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Delcath Systems' Total Liab and Total Stockholder Equity is -0.39. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Delcath Systems, assuming nothing else is changed. The correlation between historical values of Delcath Systems' Total Liab and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Delcath Systems are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Total Liab i.e., Delcath Systems' Total Liab and Total Stockholder Equity go up and down completely randomly.
Correlation Coefficient | -0.39 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most indicators from Delcath Systems' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Delcath Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Delcath Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Delcath Stock please use our How to Invest in Delcath Systems guide.The current Selling General Administrative is estimated to decrease to about 10 M. The current Issuance Of Capital Stock is estimated to decrease to about 25.4 M
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 3.6M | 2.7M | 2.1M | 2.2M | Research Development | 13.8M | 18.6M | 17.5M | 11.5M |
Delcath Systems fundamental ratios Correlations
Click cells to compare fundamentals
Delcath Systems Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Delcath Systems fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 25.9K | 2.9M | 7.1M | 8.9M | 16.2M | 17.0M | |
Total Assets | 14.2M | 34.6M | 33.1M | 17.9M | 38.6M | 21.6M | |
Other Current Liab | 3.4M | 4.7M | 4.1M | 4.5M | 5.2M | 6.4M | |
Total Current Liabilities | 15.5M | 10.0M | 6.0M | 14.7M | 16.4M | 8.9M | |
Total Stockholder Equity | (6.4M) | 22.1M | 12.0M | (5.9M) | 15.8M | 16.6M | |
Property Plant And Equipment Net | 1.6M | 2.3M | 2.0M | 1.7M | 1.5M | 1.2M | |
Net Debt | (7.1M) | (25.6M) | (6.5M) | 8.2M | (2.5M) | (2.6M) | |
Retained Earnings | (371.2M) | (395.3M) | (421.0M) | (457.5M) | (505.2M) | (479.9M) | |
Cash | 10.0M | 28.6M | 22.8M | 7.7M | 12.6M | 14.3M | |
Non Current Assets Total | 1.6M | 2.3M | 2.0M | 1.7M | 1.5M | 1.2M | |
Cash And Short Term Investments | 10.0M | 28.6M | 22.8M | 7.7M | 32.5M | 16.5M | |
Common Stock Total Equity | 103K | 1K | 60K | 100K | 115K | 109.3K | |
Liabilities And Stockholders Equity | 14.2M | 34.6M | 33.1M | 17.9M | 38.6M | 21.6M | |
Other Current Assets | 363K | 2.9M | 6.9M | 6.1M | 990K | 1.6M | |
Other Stockholder Equity | 364.8M | 417.4M | 432.8M | 451.6M | 520.6M | 546.6M | |
Total Liab | 20.6M | 12.6M | 21.2M | 23.7M | 22.8M | 24.0M | |
Property Plant And Equipment Gross | 1.6M | 1.4M | 2.0M | 6.6M | 6.5M | 6.9M | |
Total Current Assets | 12.6M | 32.3M | 31.2M | 16.2M | 37.2M | 20.4M | |
Common Stock | 1K | 60K | 79K | 100K | 228K | 246.4K | |
Short Long Term Debt Total | 2.9M | 2.9M | 16.3M | 15.9M | 10.2M | 8.8M | |
Accounts Payable | 4.5M | 1.8M | 638K | 2.0M | 1.0M | 1.5M | |
Net Receivables | 52K | 57K | 44K | 366K | 392K | 239.3K | |
Accumulated Other Comprehensive Income | 28K | (104K) | 18K | (83K) | 135K | 141.8K | |
Short Term Debt | 664K | 3.0M | 1.0M | 8.2M | 10.2M | 9.7M | |
Non Current Liabilities Total | 5.1M | 2.5M | 15.2M | 9.0M | 6.4M | 3.6M | |
Inventory | 654K | 855K | 1.4M | 2.0M | 3.3M | 3.5M | |
Other Liab | 4.0M | 2.9M | 2.1M | 1.1M | 1.2M | 2.0M | |
Net Tangible Assets | (6.4M) | 22.1M | 12.0M | (5.9M) | (6.7M) | (6.4M) | |
Property Plant Equipment | 1.6M | 2.3M | 2.0M | 1.4M | 1.6M | 1.7M | |
Net Invested Capital | (4.4M) | 24.1M | 27.6M | 9.8M | 25.9M | 27.2M | |
Net Working Capital | (2.9M) | 22.3M | 25.2M | 1.4M | 20.7M | 21.7M | |
Capital Stock | 1K | 60K | 79K | 100K | 228K | 239.4K |
Currently Active Assets on Macroaxis
When determining whether Delcath Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Delcath Systems' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Delcath Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Delcath Systems Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Delcath Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Delcath Stock please use our How to Invest in Delcath Systems guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Delcath Systems. If investors know Delcath will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Delcath Systems listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Revenue Per Share 0.505 | Quarterly Revenue Growth 14.689 | Return On Assets (0.82) | Return On Equity (4.79) |
The market value of Delcath Systems is measured differently than its book value, which is the value of Delcath that is recorded on the company's balance sheet. Investors also form their own opinion of Delcath Systems' value that differs from its market value or its book value, called intrinsic value, which is Delcath Systems' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Delcath Systems' market value can be influenced by many factors that don't directly affect Delcath Systems' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Delcath Systems' value and its price as these two are different measures arrived at by different means. Investors typically determine if Delcath Systems is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Delcath Systems' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.